Third international stroke trial.
Whiteley
William
W
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK. wwhitele@staffmail.ed.ac.uk
Lindley
Richard
R
Wardlaw
Joanna
J
Sandercock
Peter
P
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D012107:Research Design; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator